BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
 |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
United Kingdom Statutory Instruments |
||
|
You are here: BAILII >> Databases >> United Kingdom Statutory Instruments >> The Misuse of Drugs (Designation) (Amendment) (No. 2) (England, Wales and Scotland) Order 2017 No. 1118 URL: http://www.bailii.org/uk/legis/num_reg/2017/uksi_20171118_en_1.html |
||
[New search] [Printable PDF version] [Help]
Statutory Instruments
Dangerous Drugs, England And Wales
Dangerous Drugs, Scotland
Made
16th November 2017
Laid before Parliament
20th November 2017
Coming into force
27th November 2017
The Secretary of State, in exercise of the powers conferred by section 7(4) of the Misuse of Drugs Act 1971(1), and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 7(7) of that Act, makes the following Order:
1.-(1) This Order may be cited as the Misuse of Drugs (Designation) (Amendment) (No. 2) (England, Wales and Scotland) Order 2017 and comes into force on the 27th November 2017.
(2) This Order extends to England and Wales and Scotland.
2.-(1) The Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015(2) is amended as follows.
(2) In paragraph 1(a) of Part 1 of the Schedule after "Methylnaphthidate (HDMP-28)" insert-
"N-methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine or MPA)".
Ben Wallace
Minister of State
Home Office
16th November 2017
(This note is not part of the Order)
Section 7(3) of the Misuse of Drugs Act 1971 requires regulations to be made to allow the use for medical purposes of the drugs which are subject to control under that Act. Section 7(3) does not apply to any drug designated by order under section 7(4) as a drug to which section 7(4) is to apply. This Order amends the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015 by inserting the drug known as methiopropamine or MPA into Part 1 of the Schedule to that Order.
A full impact assessment of the effect that this instrument will have on the costs of business and the voluntary sector is available and is published with the Explanatory Memorandum alongside the instrument on www.legislation.gov.uk.
S.I. 2015/704 as amended by S.I. 2016/1124 and S.I. 2017/632.
